Clinical Trials Logo

Clinical Trial Summary

Scheduled, low-dose quetiapine is effective in preventing delirium in high-risk critically ill, trauma/surgical patients. Prophylaxis also reduced ventilator duration and ICU length of stay.


Clinical Trial Description

Objective: To evaluate the efficacy of scheduled quetiapine for delirium prophylaxis in critically ill, trauma/surgical patients identified as high-risk for delirium utilizing a validated prediction model.

Design: Prospective, open-label, single-center study. Setting: Trauma/surgical intensive care unit at an academic medical center. Patients: Eighty two adult trauma/surgical patients who were admitted to the intensive care unit and were at high-risk for the development of delirium (PRE-DELIRIC Score ≥50%, past medical history of dementia, past medical history of alcohol misuse, or past medical history of drug abuse).

Interventions: Patients were randomized by unit location to receive pharmacologic prophylaxis for delirium (quetiapine 12.5 mg every 12 hours) or no pharmacologic prophylaxis for delirium within forty-eight hours of admission to the intensive care unit.

Measurements: The primary end point was the incidence of delirium during admission to the intensive care unit (ICU). Secondary end points included time to onset of delirium, ICU and hospital lengths of stay, ICU and hospital mortality, duration of mechanical ventilation, and adverse events. Delirium was assessed using the confusion assessment method for the intensive care unit. ;


Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT02612948
Study type Interventional
Source University of Tennessee Graduate School of Medicine
Contact
Status Completed
Phase Phase 4
Start date November 2013
Completion date June 2014

See also
  Status Clinical Trial Phase
Completed NCT00723580 - Actigraphic Analysis of Treatment Response N/A
Completed NCT01050478 - IMPACT: A Study to Explore the Efficacy and Safety of Paliperidone ER in Patients With Acute Agitation Phase 4
Completed NCT00001770 - Progestin (Progesterone-Like Hormones) Induced Dysphoria (Depressed Mood, Irritability, Anxiety) N/A
Completed NCT01362959 - Nicotine Replacement Therapy in the Intensive Care Unit Phase 4
Completed NCT02361476 - Does Intraoperative Clonidine Reduce Post Operative Agitation in Children? Phase 4
Completed NCT02256358 - Comparison of Effects of Intravenous Midazolam and Ketamine on Emergence Agitation N/A
Recruiting NCT01578161 - The Effect of Dexmedetomidine on Emergence Agitation in Children Undergoing a Surgery Under Desflurane Anesthesia Phase 4
Completed NCT00161473 - Alzheimer's in Long-Term Care--Treatment for Agitation N/A
Recruiting NCT02617056 - Objective Assessment of Behavioral Associations of Patients With Dementia
Completed NCT03216941 - Randomised Trial Ketiapine Olanzapine Fast Sedation Agitated Patients Emergency Ward Phase 4
Completed NCT02383004 - Acupuncture for the Prevention of Emergence Delirium in Children Undergoing Myringotomy Tube Placement N/A
Completed NCT01485692 - Four Interventions in the Management of Psychomotor Agitation, Safety and Efficacy Evaluation N/A
Completed NCT00260624 - Escitalopram Treatment of Patients With Agitated Dementia Phase 4
Completed NCT02027844 - Cartoon Distraction and Parental Presence on Anxiety in Pediatric Anesthesia N/A
Completed NCT01750541 - Haloperidol vs. Valproate in Agitation Phase 3
Recruiting NCT00122759 - Ketamine Sedation in Mechanically Ventilated Patients N/A
Completed NCT00122733 - Loxapine and Weaning From Ventilator N/A
Not yet recruiting NCT04959279 - ED-TREAT (Early Detection and Treatment to Reduce Events With Agitation Tool) Compared to Usual Care N/A
Not yet recruiting NCT04148963 - A Study of Staccato Loxapine (ADASUVE®) for Inhalation Phase 3